Cognition Disorder
40
7
10
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 40 trials
100.0%
+13.4% vs benchmark
8%
3 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 14 completed trials
Clinical Trials (40)
Cognitive and Speech Disorders in Children With Congenital Heart Defects
Interventions in Mathematics and Cognitive Skills
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study
Polyamine Treatment in Elderly Patients With Coronary Artery Disease
REPAIR Sleep Study
MEOP - Multidimensional Evaluations in Oncological Psychiatry
Nutrition-based Interventions to Prevent Cognitive Decline
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Inflammatory Markers and Level of Cortical Hyperactivity
Depth of Anesthesia on Postoperative Delirium and Cognitive After Surgery
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical
NeuroCognition After Carotid Recanalization
The Impact TDCS-linked Motor and Cognitive Training Gains in Parkinson's Disease
The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
The Trajectory and Influencing Factors of Cognitive Level in ICU Delirium Patients After Transfer Out of the ICU
Portable Mixed Reality-based Platform for Assessment of Progress in Multisensory Rehabilitation Strategies Post-TBI
Computerized Training of Attention and Working Memory in Post COVID-19 Patients With Cognitive Complaints
Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study
Neuroimmune Dysfunction in Alcohol Use Disorder